Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Starting June 1, the drugmaker said Airsupra, Bevespi, Breztri and Symbicort will cost most patients ... SEE MORE: You can soon buy an over-the-counter continuous glucose monitor AstraZeneca's ...